PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT

The present invention provides a compound having the basic structure shown by Formula (I) in which the indole ring and the pyrazolopyridine structure is bound through a substituent, a salt thereof or a solvate of either the compound or a salt of the compound, as well as a preventative agent or a the...

Full description

Saved in:
Bibliographic Details
Main Authors SHIRAISHI, Takuya, YOSHINO, Hitoshi, NISHIMOTO, Masahiro, TANIDA, Satoshi, AOKI, Masahide, KAWAI, Takahiro, TSUCHIYA, Satoshi, KASHIWAGI, Hirotaka, KAMON, Takuma, HORI, Nobuyuki, NISHIMURA, Yoshikazu, OGURI, Kyoko, MATSUO, Atsushi, SATO, Tsutomu, OGAWA, Hiroko, FURUTA, Yoshiyuki, YOSHIDA, Shoshin
Format Patent
LanguageEnglish
Published 25.07.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides a compound having the basic structure shown by Formula (I) in which the indole ring and the pyrazolopyridine structure is bound through a substituent, a salt thereof or a solvate of either the compound or a salt of the compound, as well as a preventative agent or a therapeutic agent for non-insulin-dependent diabetes mellitus (Type 2 diabetes) or obesity containing such compound, salt or solvate as an active ingredient.
Bibliography:Application Number: US202418584672